Synergistic effect of 17-allylamino-17-demethoxygeldanamycin with dehydroxymethylepoxyquinomicin on the human anaplastic thyroid carcinoma cell line KTC2

The use of targeted inhibitors has shown promise as an effective approach in cancer therapy. However, targeted therapies based only on one drug, such as 17-allylamino-17-demethoxygeldanamycin (17-AAG), have limited success, partly because cancer cells engage alternate pathways for survival and proli...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Todorović Lidija, Stamenković Gorana, Vučetić-Tadić Biljana, Umezawa Kazuo, Božović Ana, Yamashita Shunichi, Stanojević Boban
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	University of Belgrade, University of Novi Sad 2021-01-01
Reeks:	Archives of Biological Sciences
Onderwerpen:	nf-κb inhibitor hsp90 inhibitor synergy targeted inhibitor combined treatment
Online toegang:	http://www.doiserbia.nb.rs/img/doi/0354-4664/2021/0354-46642000055T.pdf
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!